北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第一临床医学院  > 期刊论文
学科主题: 临床医学
题名:
Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese women
作者: Lin, S-Q.1; Sun, L-Z.2; Lin, J-F.3; Yang, X.4; Zhang, L-J.5; Qiao, J.6; Wang, Z-H.7; Xu, Y-X.8; Xiong, Z-A.9; Zhou, Y-Z.1; Wang, M-L.2; Zhu, J.3; Chen, S-R.4; Su, H.5; Yang, C-S.6; Wang, S-H.7; Zhang, Y-Z.8; Dong, X-J.9
关键词: DROSPIRENONE ; ESTRADIOL ; HORMONE REPLACEMENT THERAPY ; HORMONE THERAPY ; MENOPAUSE ; VASOMOTOR SYMPTOMS ; RANDOMIZED CONTROLLED TRIAL
刊名: CLIMACTERIC
发表日期: 2011-08-01
DOI: 10.3109/13697137.2011.553971
卷: 14, 期:4, 页:472-481
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Obstetrics & Gynecology
研究领域[WOS]: Obstetrics & Gynecology
关键词[WOS]: QUALITY-OF-LIFE ; MENOPAUSAL SYMPTOMS ; DOUBLE-BLIND ; AGE ; DETERMINANTS ; PROGESTOGENS ; MULTICENTER ; POPULATION ; EFFICACY ; ESTROGEN
英文摘要:

Objectives Drospirenone is a novel progestogen that, combined with 17 beta-estradiol, reduces the frequency and severity of menopausal vasomotor symptoms (VMS) in different populations. This double-blind, multicenter study compared the efficacy, safety and tolerability of 2 mg drospirenone/1 mg estradiol (DRSP/E2) vs. placebo in Chinese postmenopausal women with moderate to severe VMS.

Methods Women, aged 45-65 years, were randomized to DRSP/E2 (n = 183) or placebo (n = 61) once daily for four 28-day cycles. Changes in the frequency and severity of hot flushes were analyzed as primary variables, together with other climacteric and urogenital symptoms, clinical global improvement, adverse events and physical/gynecological parameters.

Results Relative changes in numbers of hot flushes/week were -80.4% for DRSP/E2 vs. -51.9% for placebo (treatment difference -28.5%, p < 0.0001). There were trends toward a greater reduction in severity of hot flushes with DRSP/E2 treatment. Patients treated with DRSP/E2 were more often free from sweating episodes (p < 0.0001) and vaginal dryness (p = 0.0008). Other climacteric symptoms, including nervousness and pollakisuria, followed a trend of greater response with DRSP/E2. Similar to other combination HRT regimens, DRSP/E2 increased occurrences of bleeding, but these decreased over time. Adverse events in patients treated with DRSP/E2 were mostly mild to moderate and withdrawal rates were low.

Conclusions Daily treatment of postmenopausal Chinese women with DRSP/E2 for 16 weeks significantly reduced the incidence of hot flushes and demonstrated advantages vs. placebo for other climacteric symptoms. These results indicate that DRSP/E2 is effective, safe and well tolerated in postmenopausal Chinese women.

语种: 英语
项目资助者: Bayer Schering Pharma AG
WOS记录号: WOS:000292779500011
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/56678
Appears in Collections:北京大学第一临床医学院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Peking Univ, Hosp 1, Beijing 100871, Peoples R China
2.Peking Chao Yang Hosp, Beijing, Peoples R China
3.Peking Univ, Hosp 3, Beijing 100871, Peoples R China
4.Shandong Univ, Qilu Hosp, Jinan 250100, Peoples R China
5.Beijing Union Med Coll Hosp, Beijing, Peoples R China
6.Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Peoples R China
7.Fudan Univ, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China
8.Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China
9.Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China

Recommended Citation:
Lin, S-Q.,Sun, L-Z.,Lin, J-F.,et al. Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese women[J]. CLIMACTERIC,2011,14(4):472-481.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Lin, S-Q.]'s Articles
[Sun, L-Z.]'s Articles
[Lin, J-F.]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Lin, S-Q.]‘s Articles
[Sun, L-Z.]‘s Articles
[Lin, J-F.]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit
所有评论 (0)
暂无评论
 
评注功能仅针对注册用户开放,请您登录
您对该条目有什么异议,请填写以下表单,管理员会尽快联系您。
内 容:
Email:  *
单位:
验证码:   刷新
您在IR的使用过程中有什么好的想法或者建议可以反馈给我们。
标 题:
 *
内 容:
Email:  *
验证码:   刷新

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace